rs2271933 — HCRTR1 Ile408Val

HCRTR1 Ile408Val — The Orexin Receptor Migraine Variant

The orexin system¹¹ orexin system
Also called hypocretin. A pair of neuropeptides (orexin-A and orexin-B) produced by a small cluster of neurons in the lateral hypothalamus. Named from the Greek "orexis" (appetite), but now known to regulate far more than hunger is one of the brain's master regulators, orchestrating the balance between wakefulness and sleep, appetite and satiety, arousal and calm. The HCRTR1 gene encodes the orexin receptor 1 (OX1R)²² orexin receptor 1 (OX1R)
A G-protein coupled receptor with preferential affinity for orexin-A. Widely expressed in the locus coeruleus, prefrontal cortex, hippocampus, and amygdala — brain regions governing alertness, fear, and memory, the primary target for orexin-A signaling. The rs2271933 variant causes an isoleucine-to-valine substitution at position 408, altering the receptor's cytoplasmic tail and potentially changing how it couples to downstream G-protein signaling cascades.

The Mechanism

The Ile408Val substitution occurs in the C-terminal intracellular domain³³ C-terminal intracellular domain
The portion of the receptor inside the cell, responsible for interacting with G-proteins and other signaling molecules that relay the orexin signal to cellular machinery of HCRTR1, a region critical for G-protein coupling and signal transduction. While the precise functional consequence of this amino acid change has not been fully characterized in vitro, the valine substitution may alter the receptor's interaction with intracellular signaling partners, subtly shifting orexin-A signal strength or duration. This is consistent with findings that the A allele is associated with altered hypocretin-1 concentrations⁴⁴ altered hypocretin-1 concentrations
Kowalska M et al. The New G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients. Front Mol Neurosci, 2018 and modified serotonin levels, suggesting downstream effects on neurotransmitter systems implicated in both migraine and mood.

The Evidence

The strongest evidence links rs2271933 to migraine. A case-control study of 384 migraineurs and 259 controls⁵⁵ case-control study of 384 migraineurs and 259 controls
Rainero I et al. Evidence for an association between migraine and the hypocretin receptor 1 gene. J Headache Pain, 2011 found the A allele carried an OR of 1.42 (95% CI 1.11-1.81) for migraine risk, with the association specific to migraine without aura. In women, the effect was more pronounced (OR 1.80, 95% CI 1.22-2.65, p=0.003), while no significant association emerged in men.

The same research group found the A allele associated with major mood disorders⁶⁶ major mood disorders
Rainero I et al. Association between major mood disorders and the hypocretin receptor 1 gene. J Affect Disord, 2011 at OR 1.60 (95% CI 1.22-2.10) in 229 patients versus 259 controls, with the association confirmed in the unipolar depression subgroup.

A large panic disorder meta-analysis⁷⁷ panic disorder meta-analysis
Gottschalk MG et al. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. Transl Psychiatry, 2019 combined two independent cohorts (613 patients, 2,512 controls) and found a striking association (allelic OR 1.51, p=4.2x10^-7), particularly in women (recessive OR 2.59, p=9.8x10^-9). Risk allele carriers also showed poorer response to cognitive behavioral therapy and altered brain activation patterns — decreased inferior frontal gyrus and increased locus coeruleus⁸⁸ locus coeruleus
The brain's primary norepinephrine-producing nucleus, critical for arousal, attention, and the fight-or-flight response activation during attention tasks.

In two Estonian birth cohorts⁹⁹ Estonian birth cohorts
Harro J et al. Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour. Neuropharmacology, 2019 totaling ~1,238 participants, A/A homozygotes reported higher aggression scores, with the effect moderated by stressful life events, particularly in women.

Practical Implications

The convergence of migraine, panic disorder, mood disorders, and altered arousal in one receptor variant reflects the orexin system's central role in regulating the brain's overall excitability state. The A allele appears to shift the orexin signaling balance toward heightened arousal reactivity — useful for vigilance, but at the cost of increased vulnerability to conditions driven by neural hyperexcitability.

For migraine specifically, the orexin connection opens a distinct management angle. Orexin receptor antagonists (suvorexant, lemborexant) are FDA-approved for insomnia and are being investigated for migraine prevention. A/A carriers who experience both migraine and sleep difficulties may be particularly suited for discussion of these agents with their physician. The strong female predominance in the associations suggests hormonal modulation of orexin signaling, consistent with the known estrogen-orexin interaction.

Interactions

HCRTR1 rs2271933 likely interacts with the broader arousal and neuropeptide network. The neuropeptide S receptor gene NPSR1 (rs324981) is a functionally analogous variant — both encode arousal-promoting receptor changes associated with panic disorder, and carriers of risk alleles at both loci may experience compounded arousal dysregulation. BDNF Val66Met (rs6265) could modulate the stress resilience component, as both BDNF and orexin pathways converge on prefrontal-limbic circuits. However, specific gene-gene interaction studies for HCRTR1 rs2271933 combined with these variants have not yet been published, so these interactions remain theoretical.